Welcome to Sequence Card of Peptide
Details of CPPsite entry with Sequence AGYLLGK[KK2sa4qn4]INLKALAALAKKIL |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | AGYLLGK[KK2sa4qn4]INLKALAALAKKIL |
| CPPsite ID | 3003, 3004, |
| PEPTIDE NAME | Pepfect 5, Pepfect 6 |
| CHIRALITY | Modified, Modified |
| LINEAR/CYCLIC | Linear, Linear |
| SOURCE | Synthetic, Synthetic |
| CATEGORY | Amphipathic, Amphipathic |
| SUB CELLULAR LOCALIZATION | NA, NA |
| N-TERMINAL MODIFICATION | Stearylation, Stearylation |
| C-TERMINAL MODIFICATION | Amidation, Amidation |
| CHEMICAL MODIFICATION | sa: succinicc acid, qn: novel 2-4 ring systems such as quinoline and naphthalene analogues, sa: succinicc acid, qn: novel 2-4 ring systems such as quinoline and naphthalene analogues |
| UPTAKE EFFICIENCY | NA, NA |
| PROPOSED UPTAKE MECHANISM | Endocytosis, Endocytosis |
| INVITRO/INVIVO | In vitro, In vitro |
| CELL LINE | Hela, Luciferase stable BHK21 cells, Hela, Luciferase stable BHK21 cells, luciferase stable osteosarcoma cells (U2OS) |
| In VIVO MODEL | NA, NA |
| CARGO | Nucleic acid (anti-miR21 ON, siRNA), Nucleic acid (siRNA) |
| PMID | Unknown |
| PATENT | US 2014/0140929 A1, US 2014/0140929 A1 |
| Tertiary Structure (Technique) | Not Predicted), Not Predicted), |